PROPRIETARY DATA
Per-formula, per-vessel process traces paired with expert corrections. Not scrapeable, not purchasable, not synthesisable.
ABOUT
Serumon exists because the people who can tell by feel whether an emulsion is right, and by eye whether a shade is on standard, are a small and shrinking population — and nothing in the plant is capturing what they know before they leave.
Five agents, one runtime, one audit trail.
THE THESIS
Cosmetics and personal care is a $500B+ industry where the product is a precisely engineered emulsion, suspension or dispersion that must look, feel, spread and perform identically in every jar, and match a brand shade to an imperceptible tolerance, at massive scale, under intense brand, cost and regulatory pressure.
The work is craft-bound, chemistry-critical, quality-sensitive and high-mix — a textbook case for autonomy. And yet most plants still run manual compounding recipes, eyeball shade matching and reactive lab QC.
That gap is the company. Not a dashboard on top of the gap: a system of action inside it.
THE OPPORTUNITY
MARKET FIGURES ARE SERUMON ESTIMATES; SOM IS [ASPIRATIONAL].
BRAND PILLARS
Grounded, auditable, GMP and quality-grade. Every claim traceable to evidence, including on this website.
The product performs the work rather than assisting with it. A copilot that only advises does not move the numbers.
Priced and measured on value. If the metric does not move, the commercial consequence was agreed in advance.
Built for cosmetics specifically. Emulsions, shade standards and fill formats are not a configuration of a generic platform.
PRINCIPLES
Grounding, audit, human-in-the-loop and graduated control — in that order, every time, on every formula.
Every supervised correction trains the system. The craft becomes an asset that appreciates.
One vessel, one metric, one quarter. Broad platform pitches produce broad platform failures.
Expansion is the growth engine: more lines, more modules, more sites, higher autonomy.
ROADMAP
THE MOAT
Per-formula, per-vessel process traces paired with expert corrections. Not scrapeable, not purchasable, not synthesisable.
Write access into vessels, fillers and robot cells earned through validation. Rip-and-replace means re-validating a plant.
The plant’s own institutional knowledge encoded in a model. Switching means losing the craft of people who already left.
Only a platform spanning make to release can learn which compounding signature causes which stability failure.
A GMP-grade audit trail and validation approach are years of unglamorous work that a demo cannot shortcut.
A horizontal industrial-AI vendor will not build spectrophotometric shade prescription for foundation. We only build that.
HONEST STATUS
INCORPORATION, HEADCOUNT AND COMMERCIAL MILESTONES ARE [ASPIRATIONAL] UNTIL COMPLETED AND VERIFIABLE.
NVIDIA INCEPTION
Serumon is an independent startup building original physical-AI software, not a services division, a reseller or an AI wrapper. The proprietary technology is the plant-edge autonomy layer: multimodal perception, process world models, constrained agents, digital-twin simulation and closed-loop action policies.
GPU compute is a hard requirement across all five products — real-time multimodal perception, on-site inference serving, large-scale training, synthetic data generation and constrained optimisation. CPU-only cannot serve this loop inside a plant control window.
GPU PROFILE BY PRODUCT
Become the autonomous operations layer for the world’s cosmetics manufacturing — every batch compounded, shaded and filled on Serumon.
ABOUT FAQ
Small and technical. Precise headcount, incorporation status and funding details are not published here because they change quickly and because stating them inaccurately would contradict everything else on this site.
Funding status is discussed directly with design partners, investors and enterprise buyers under NDA. We would rather answer that in a room than in a marketing paragraph.
Because shade is judged by eye, emulsions are a genuine black art, and the craft-labour constraint is acute — while regulation is serious without being as slow as pharmaceutical validation. It is the highest-value place to prove closed-loop manufacturing autonomy.
If plants will not grant write access at any level of proof, Serumon becomes a very good prediction product rather than an autonomy platform. That is the core risk and we track it explicitly.
WORK WITH US
Design partners, engineers and investors: the interesting conversations all start the same way — with a real vessel and a real number.